ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say

December 19, 2014

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

Also in this 8-page issue: Tony Hunter, Raymond DuBois win AACR Landon prizes.

March 5, 2004

NCI, MABCO Publish Clinical Trials Web Site

September 6, 1996

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013